Adherence of pharmaceutical advertisements in medical journals to FDA guidelines and content for safe prescribing

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Korenstein, Deborah ^a   Keyhani, Salomeh ^a,b   Mendelson, Ali ^c   Ross, Joseph S ^d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; DRUG CONTROL; DRUG INFORMATION; DRUG MARKETING; DRUG QUALITY; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; MEDICAL LITERATURE; MEDICAL RESEARCH; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRESCRIPTION; PRODUCT DEVELOPMENT; PUBLISHING; RISK ASSESSMENT; ADVERTIZING; CROSS-SECTIONAL STUDY; DRUG INDUSTRY; DRUG THERAPY; HUMAN; METHODOLOGY; PUBLIC HEALTH; PUBLICATION; STANDARD; STATISTICS; UNITED STATES;

DRUG;

ADVERTISING AS TOPIC; CROSS-SECTIONAL STUDIES; DRUG INDUSTRY; DRUG PRESCRIPTIONS; DRUG THERAPY; GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; HUMANS; PERIODICALS AS TOPIC; PHARMACEUTICAL PREPARATIONS; PUBLIC HEALTH; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 80051717782     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023336     Document Type: Article

References (27)

1. Neslin S, (2001) RAPP Study Executive Summary. Available from:http://www.docstoc.com/docs/69287888/ROI-Analysis-of-Pharmaceutical-Promotion-(RAPP)-An-Independent.
2. Spurling GK, Mansfield PR, Montgomery BD, Lexchin J, Doust J, et al. (2010) Information from Pharmaceutical Companies and the Quality, Quantity, and Cost of Physicians' Prescribing: A Systematic Review. PLoS Medicine 7 (10): e1000352 doi:10.1371/journal.pmed.1000352.
3. Dubois R, (2003) Pharmaceutical Promotion: Don't Throw The Baby Out With The Bathwater. Health Affairs (Millwood) W3: 96-103.
4. Lexchin J, (1999) How patient outcomes are reported in drug advertisements-Review of Canadian medical journals. Canadian Family Physician 45: 1213-1216.
5. Othman N, Vitry A, Roughead EE, (2009) Quality of Pharmaceutical Advertisements in Medical Journals: A Systematic Review. PLoS ONE 4 (7): e6350 doi:10.1371/journal.pone.0006350.
6. Lankinen KS, Levola T, Marttinen K, Puumalainen I, Helin-Salmivaara A, (2004) Industry guidelines, laws and regulations ignored: quality of drug advertising in medical journals. Pharmacoepidemiology and Drug Safety 13: 789-795.
7. Mindell J, Kemp T, (1997) Only two fifths of advertisements cited published, peer reviewed references. BMJ 315: 1622.
8. Smart S, Williams C, (1997) Half of drug advertisements in BMJ over six months cited no supporting evidence. BMJ 315: 1622.
9. Spielmans GI, Thielges SA, Dent AL, Greenberg RP, (2008) The Accuracy of Psychiatric Medication Advertisements in Medical Journals. The Journal of Nervous and Mental Disease 196: 267-273.
10. Villanueva P, Peiro S, Librero J, (2003) Accuracy of pharmaceutical advertisements in medical journals. The Lancet 361: 27-32.
11. Montgomery BD, Mansfield PR, Spurling GK, Ward AM, (2008) Do advertisements for antihypertensive drugs in Australia promote quality prescribing? A cross-sectional study. BMC Public Health 8: 167.
12. Brody H, Light DW, (2011) The Inverse Benefit Law: How Drug Marketing Undermines Patient Safety and Public Health. American Journal of Public Health 101: 399-404.
13. Thaul S, (2009) Direct to Consumer Advertising of Prescription Drugs. Congressional Research Service, R40590. Available from:http://www.law.umaryland.edu/marshall/crsreports/crsdocuments/RL3285303252005.pdf.
14. Gagnon M-A, Lexchin J, (2008) The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States. PLoS Medicine 5 (1): e1 doi:10.1371/journal.pmed.0050001.
15. Hamburg MA, Dear Healthcare Professional Letter. Available from:http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/DrugMarketingAdvertisingandCommunications/UCM211560.pdf.
16. Wilkes MS, Doblin BH, Shapiro MF, (1992) Pharmaceutical Advertisements in Leading Medical Journals: Experts Assessments. Annals of Internal Medicine 116: 912-919.
17. Food and Drug Administration. Prescription Drug Advertising (2001) Available from:http://edocket.access.gpo.gov/cfr_2001/aprqtr/pdf/21cfr202.1.pdf.
18. McAlister FA, Straus SE, Guyatt GH, Haynes RB, (2000) Users' Guides to the Medical Literature XX. Integrating Research Evidence With the Care of the Individual Patient. JAMA 283: 2829-2836.
19. Food and Drug Administration 2009 Warning Letters and Untitled Letters to Pharmaceutical Companies. Available from:http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/ucm055773.htm.
20. Fugh-Berman A, Alladin K, Chow J, (2006) Advertising in Medical Journals: Should Current Practice Change? PLoS Medicine 3 (6): e130 doi:10.1371/journal.pmed.0030130.
21. Spiller LD, Wymer WWJ, (2001) Physicians' Perceptions and Uses of Commercial Drug Information Sources: An Examination of Pharmaceutical Marketing to Physicians. Health Marketing Quarterly 19: 91-106.
22. Norris P, Herxheimer A, Lexchin J, Mansfield P, (2004) Drug Promotion-What We Know, What We Have Yet to Learn-Reviews of Materials in the WHO/HAI Database on Drug Promotion-EDM Research Series No. 032. Available from:http://apps.who.int/medicinedocs/en/d/Js8109e/2.html.
23. Korenstein D, Keyhani S, Ross J, (2010) Physician attitudes toward industry: a view across the specialties. Archives of Surgery 145: 570-577.
24. McGettigan P, Golden J, Fryer J, Chan R, Feely J, (2001) Prescribers prefer people: The sources of infomration used by doctors for prescribing suggests that the medium is more important than the message. British Journal of Clinical Pharmacology 51: 184-189.
25. Santiago MG, Bucher HC, Nordmann AJ, (2008) Accuracy of drug advertisements in medical journals under new law regulating the marketing of pharmaceutical products in Switzerland. BMC Medical Informatics and Decision Making 8: 61.
26. Shuchman M, (2007) Drug Risks and Free Speech-Can Congress Ban Consumer Drug Ads? New England Journal of Medicine 356: 2236-2239.
27. FDA Regulates Prescription Drug Promotion (2003) The Senate Special Committee on Aging, United States Department of Health and Human Services. Available from:http://www.hhs.gov/asl/testify/t030722b.html.